To read more on this topic click here.
Scottish university reveals multimillion-pound Parkinson’s research partnership
News
Author: Roisin McCormackPublished: 10 July 2019
Prep:
Cook:
Serves:
The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s.
Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition.
The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development.
Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together.
“This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”
Read more:
Parkinson’s may originate in the gut, says new study
Acupuncture may alleviate Parkinson’s symptoms
Last Month
Next Month
Share this story
Related articles
Europe
My PD Journey: landmark Parkinson’s summit highlights urgent need for new composite scale
European coalition set to roll out new and simple composite scale
READ MORE
Interviews
“We want the world to walk with us,” says Parkinson’s Unity Walk leader
2016 Parkinson’s Unity Walk hopes to raise more than US$1.7m
READ MORE
Perspectives
Paws for Parkinson’s: the perks and the quirks of service dogs
‘Man’s best friend’ can provide a stabilising presence
READ MORE
Comments